quinidine has been researched along with alanine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Förster, W; Mentz, P; Schmidt, R | 1 |
| Blackburn, MG; Ellis, SW; Harlow, J; Hayhurst, GP; Larsson, C; Lennard, MS; Lightfoot, T; Lim, CK; Mahling, J; Rowland-Yeo, K; Smith, G; Tucker, GT; Wolf, CR | 1 |
| Bett, GC; Rasmusson, RL | 1 |
| Flanagan, JU; Kemp, CA; Maréchal, JD; McLaughlin, LA; Paine, MJ; Roberts, GC; Sutcliffe, MJ; Ward, CJ; Wolf, CR | 1 |
| Julínek, O; Lindner, W; Urbanová, M | 1 |
| Leake, BF; Meiler, J; Roden, DM; Sanders, CR; Smith, JA; Yang, T | 1 |
7 other study(ies) available for quinidine and alanine
| Article | Year |
|---|---|
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
[The effect of cardiovascular agents on amino acid aryl amidase].
Topics: Ajmaline; Alanine; Amides; Aminohydrolases; Animals; Anti-Arrhythmia Agents; Azo Compounds; Cardiac Glycosides; Humans; Propranolol; Quinidine; Rabbits; Strophanthins | 1973 |
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
Topics: Alanine; Amino Acid Substitution; Aspartic Acid; Binding Sites; Catalytic Domain; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Enzyme Inhibitors; Kinetics; Ligands; Metoprolol; Mutagenesis, Site-Directed; Oxidation-Reduction; Propranolol; Quinidine; Quinine; Serine; Substrate Specificity; Yeasts | 2000 |
Inactivation and recovery in Kv1.4 K+ channels: lipophilic interactions at the intracellular mouth of the pore.
Topics: Alanine; Allosteric Regulation; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; Cytoplasm; Female; Gene Deletion; Intracellular Fluid; Kv1.4 Potassium Channel; Molecular Conformation; Oocytes; Peptide Fragments; Permeability; Point Mutation; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Valine; Xenopus laevis | 2004 |
Why is quinidine an inhibitor of cytochrome P450 2D6? The role of key active-site residues in quinidine binding.
Topics: Alanine; Aspartic Acid; Binding Sites; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Escherichia coli; Glutamic Acid; Humans; Kinetics; Mass Spectrometry; Mixed Function Oxygenases; Models, Molecular; Mutation; Oxidoreductases, O-Demethylating; Protein Binding; Protein Structure, Tertiary; Quinidine; Spectrophotometry; Substrate Specificity | 2005 |
Study of stereoselective interactions of carbamoylated quinine and quinidine with 3,5-dinitrobenzoyl α-amino acids using VCD spectroscopy in the region of C−H stretching vibrations.
Topics: Absorption; Alanine; Amino Acids; Circular Dichroism; Dinitrobenzenes; Glycine; Hydrophobic and Hydrophilic Interactions; Isoleucine; Leucine; Quinidine; Quinine; Stereoisomerism; Valine; Vibration | 2011 |
An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1.
Topics: Alanine; Allosteric Regulation; Animals; Binding Sites; Cell Line; CHO Cells; Cricetinae; Cysteine; Heart; Humans; KCNQ1 Potassium Channel; Models, Molecular; Mutagenesis, Site-Directed; Myocardium; Quinidine | 2013 |